Fabián Tibaldi - Concepedia

Author

Fabián Tibaldi

Also Known As

F Tibaldi, F. S. Tibaldi, F. Tibaldi, Fabian S. Tibaldi, Fabian Tibaldi, Fabián S. Tibaldi, Fabián S. Tibaldi, Fabián Tibaldi, Tibaldi, Fabian

Publications

998

Citations

H-Index

Concepts

All Affiliations

Universidad de Buenos Aires GlaxoSmithKline (Belgium)Eli Lilly (United States)Fundación Ciencias Exactas y Naturales KU Leuven

About

Fabián Tibaldi is an author at Universidad de Buenos Aires specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	227
2	Engineering	1	1	44
3	Health Sciences	1	1	12
4	Public Health	1	1	44
5	Biostatistics	1	1	44

Fabián Tibaldi

Publications

959

Citations

H-Index

Page 1

	Year	Citations
Indication for thresholds of chromosome non-disjunction versus chromosome lagging induced by spindle inhibitors <i>in vitro</i> in human lymphocytes Azeddine Elhajouji, Fabián Tibaldi, Micheline Kirsch‐Volders Mutagenesis	1997	166
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆ Marie‐Pierre David, Koen Van Herck, Karin Hardt, Gynecologic Oncology Vaccination-18 AntibodiesAntibody Responses☆Cervical CancerVaccine Development	2009	154
A 5‐week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long‐acting glucagon‐like peptide‐1 analogue, in patients with type 2 diabetes Peggy L. Barrington, Jenny Y. Chien, H. D. Hollis Showalter, Diabetes Obesity and Metabolism	2011	109
Psychomotor development in Argentinean children aged 0–5 years Horacio Lejarraga, María Cecilia Pascucci, Sara Krupitzky, Paediatric and Perinatal Epidemiology	2002	75
LY2189265, a long‐acting glucagon‐like peptide‐1 analogue, showed a dose‐dependent effect on insulin secretion in healthy subjects Peggy L. Barrington, Jenny Y. Chien, Fabián Tibaldi, Diabetes Obesity and Metabolism	2011	72
Prentice's Approach and the Meta‐Analytic Paradigm: A Reflection on the Role of Statistics in the Evaluation of Surrogate Endpoints Ariel Alonso, Geert Molenberghs, Tomasz Burzykowski, Biometrics	2004	54
Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease Anne Benoît, Jeanne-Marie Devaster, Meral Esen, Open Forum Infectious Diseases VaccinationVaccine SafetyInfectious Disease EpidemiologyVaccine DevelopmentHi Response	2015	49
Simplified hierarchical linear models for the evaluation of surrogate endpoints Fabián Tibaldi, José Cortiñas Abrahantes, Geert Molenberghs, Journal of Statistical Computation and Simulation EngineeringClinical EndpointComputational ComplexityData SurrogateSurrogate Endpoints	2003	44
AIR Inhaled Insulin in Subjects With Chronic Obstructive Pulmonary Disease Klaus Rave, Amparo de la Peña, Fabián Tibaldi, Diabetes Care	2007	37
Conditional mixed models with crossed random effects Fabián Tibaldi, Geert Verbeke, Geert Molenberghs, British Journal of Mathematical and Statistical Psychology	2006	32

Page 1